Safety and tolerability of antipsychotics: focus on amisulpride
Mario F Juruena1, Eduardo Pondé de Sena2, Irismar Reis de Oliveira31Stress and Affective Disorders Programme, Department of Neuroscience and Behaviour, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil ...
Mario F Juruena +2 more
doaj
Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents. [PDF]
Olasupo SB +3 more
europepmc +1 more source
Patient perspectives on antipsychotic treatments and their association with clinical outcomes
Hong Liu-Seifert1, Olawale O Osuntokun1, Jenna L Godfrey2, Peter D Feldman11Lilly Research Laboratories, Indianapolis, IN, USA; 2Durham Veterans Affairs Medical Center, Durham, NC, USAAbstract: This analysis examined patient-reported attitudes toward ...
Olawale O Osuntokun +3 more
core
Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow-up study. [PDF]
Zhuo C +10 more
europepmc +1 more source
Repurposing Antipsychotic Agents in Oncology: Mechanistic Rationale, Emerging Evidence, and Therapeutic Potential. [PDF]
Qu A +8 more
europepmc +1 more source
Risk Evaluation for Antipsychotic Agents Used in Elderly Inpatients (REPAIR). [PDF]
Yu F, Rafizadeh R, Mabasa VH, Kang N.
europepmc +1 more source
Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia. [PDF]
Li P +4 more
europepmc +1 more source
Clinician differences in attitudes and perceptions on the use of long-acting injectable antipsychotic agents in treating patients with schizophrenia: results from the US DECIDE survey. [PDF]
Velligan D +6 more
europepmc +1 more source
Preferences for Selecting and Initiating Long-Acting Injectable Antipsychotic Agents for the Treatment of Patients With Schizophrenia: Results From the US DECIDE Survey. [PDF]
Velligan D +6 more
europepmc +1 more source
Douglas L Noordsy1, Glenn A Phillips2, Daniel E Ball2, Walter T Linde-Zwirble31Department of Psychiatry, Dartmouth Medical School, Lebanon, NH, USA; 2Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA; 3ZD Associates, Perkasie, PA ...
Glenn A Phillips +3 more
core

